• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Australia·Real Estate·CHC.AX
Share

Charter Hall Group Stocks

A$ 22.63Last Updated 01.07.2026

Issuer Rating

5/7
Performance

Average

Risk

Low

Recommendation

Hold

Market Cap

A$ 7.71B

A$ 22.63
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Charter Hall Group stands as a premier integrated property entity in Australia, leveraging over three decades of profound expertise in both property investment and funds management. Our deep understanding of the property market enables us to source, allocate, oversee, and deploy capital across vital sectors, including office spaces, retail outlets, industrial and logistics facilities, and essential social infrastructure projects. Through meticulous and prudent management, we have carefully cultivated a substantial and diverse portfolio exceeding $41.8 billion in value, comprising more than 1,100 high-quality properties secured by long-term leases. Our operational philosophy is anchored by strong partnerships and rigorous financial discipline. Dedicated to serving the best interests of our clients and the broader community, we utilize a blend of deep market insight and innovative thinking to uncover and maximize value. Adopting a forward-looking perspective, our robust $6.8 billion development pipeline is committed to delivering cutting-edge, sustainable, and technologically advanced projects tailored for our clientele. The influence of our work extends broadly, encompassing everything from empowering businesses with dynamic and adaptive workplace solutions, to securing exceptional returns for investors to ensure a more prosperous retirement. This extensive impact fuels our ambition to constantly push boundaries.

Company Valuation

Overvalued
2/7

Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, over

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of CHC.AX is 25 and suggests 8.95% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

01.07.2026 20:33

"A Key Source of Value and Risk": Wall Street's Top Tech Optimist Assesses SpaceX

01.07.2026 19:21

Companies laid off employees because of artificial intelligence. Some came to regret it.

01.07.2026 18:59

Meta will launch a cloud infrastructure business. It will compete with Google and Nebius

01.07.2026 18:47

BlackRock is betting on scarce resources in AI supply chains. How should you build your portfolio?

01.07.2026 18:39

Shares of pharmaceutical company Galderma plummeted: The U.S. has halted sales of a Botox generic

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026